Advances in diagnostic testing and treatments like pyridostigmine improve the management of autonomic nervous system disorders.
Answers are grounded in this paper and cite their sources.
May support improved autonomic disorder management with antibody testing and pyridostigmine; leaves open need for prospective validation.
Autonomic nervous system dysfunction may manifest with a variety of symptoms, with orthostatic intolerance (including orthostatic hypotension or tachycardia) and sweating abnormalities (increased or decreased sweating) being common problems requiring medical evaluation and treatment. Determination of the underlying diagnosis for these symptoms is critical in terms of classification of the disorder and its prognosis. Recent advances in evaluation of patients with these conditions and treatment modalities have enabled physicians to improve overall management of patients with these disorders. These advances include testing for ganglionic acetylcholine receptor antibody in patients with suspected autoimmune autonomic neuropathy and use of pyridostigmine for treatment of patients with orthostatic hypotension or tachycardia.
No takes yet. Share an insight, caveat, or question.
Caroline M. Klein (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: